How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?

被引:6
|
作者
Schwarz P.E.H. [1 ]
Li J. [1 ]
Lindström J. [1 ]
Bergmann A. [1 ]
Gruhl U. [1 ]
Saaristo T. [1 ]
Tuomilehto J. [1 ]
机构
[1] Department of Public Health, University of Helsinki, 00300 Helsinki
关键词
Metformin; Rosiglitazone; Lifestyle Intervention; Acarbose; Diabetes Prevention;
D O I
10.1007/s11892-007-0058-7
中图分类号
学科分类号
摘要
The dramatic increase in newly diagnosed cases of type 2 diabetes (T2D) has developed into a major public hearth concern worldwide. Conversely, several clinical studies have demonstrated that preventive efforts can significantly reduce the risk of developing diabetes. There is a clear consensus that action is needed to develop targeted community-based prevention programs and strategies for T2D. Currently, numerous prevention management concepts that can be implemented into clinical practice exist in various countries. Finland is the pioneer country in implementing community-wide diabetes prevention programs. Nevertheless, population-based nationwide strategies are still lacking in virtually all countries. We report on intervention strategies to prevent T2D in people with increased diabetes risk, as well as strategies on how to implement diabetes prevention programs into the real world of public health or clinical care. The implementation of managed prevention concepts will realistically help to improve the ability to prevent T2D in the public health framework. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:353 / 362
页数:9
相关论文
共 50 条
  • [31] Dietary patterns and the risk of type 2 diabetes in overweight and obese individuals
    Bauer, Florianne
    Beulens, Joline W. J.
    van der A, Daphne L.
    Wijmenga, Cisca
    Grobbee, Diederick E.
    Spijkerman, Annemieke M. W.
    van der Schouw, Yvonne T.
    Onland-Moret, N. Charlotte
    EUROPEAN JOURNAL OF NUTRITION, 2013, 52 (03) : 1127 - 1134
  • [32] Liposuction and diabetes type 2 development risk reduction in the obese patient
    Perez, R. A.
    MEDICAL HYPOTHESES, 2007, 68 (02) : 393 - 396
  • [33] How do fruit and vegetables prevent heart disease and type 2 diabetes?
    Clifton, Peter M.
    Petersen, Kristina S.
    Blanch, Natalie
    Keogh, Jennifer B.
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (02)
  • [34] How to prevent the microvascular complications of type 2 diabetes beyond glucose control
    Valencia, Willy Marcos
    Florez, Hermes
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [35] Nonalcooholic steatohepatitis: Should we screen high-risk patients with type 2 diabetes or obesity?
    Caussy, Cyrielle
    NUTRITION CLINIQUE ET METABOLISME, 2020, 34 (02): : 122 - 129
  • [37] TYPE 2 DIABETES MELLITUS. HOW SHOULD DIABETIC DYSLIPIDEMIA BE TREATED?
    Perez, A.
    Sojo, L.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2005, 17 : 40 - 51
  • [38] Clinical commentary - Ace inhibitors should still be used in most patients with type 2 diabetes
    Saseen, J
    JOURNAL OF FAMILY PRACTICE, 2004, 53 (01): : 69 - 69
  • [39] How to prevent type 2 diabetes in women with previous gestational diabetes? A systematic review of behavioural interventions
    Pedersen, Anne Louise Winkler
    Maindal, Helle Terkildsen
    Juul, Lise
    PRIMARY CARE DIABETES, 2017, 11 (05) : 403 - 413
  • [40] Diabetes risk factors and chromium intake in moderately obese subjects with type 2 diabetes mellitus
    Juturu, Vijaya
    Daly, Anne
    Geohas, Jeff
    Finch, Manley
    Komorowski, James R.
    NUTRITION & FOOD SCIENCE, 2006, 36 (06): : 390 - 399